<p>A–B: Protection against A/California/04/2009 virus challenge. Mice intramuscularly immunized with a single dose of VLPs (10 µg) were challenged with a lethal dose (100 LD<sub>50</sub>) of A/California/04/2009 virus at week 6 post immunization. Mice (n = 12) were monitored daily for 14 days for body weight changes (A) and survival rates (B). C–D: Protection against the antigenically distant A/PR8/1934 virus (10 LD<sub>50</sub>). Body weight changes (C) and survival rates (D) are shown.</p
<p>Balb/c mice were immunized according to <a href="http://www.plosone.org/article/info:doi/10.1371/...
<p>BALB/c mice (n = 6) were immunized on day 0 and 21 with rNP (10 µg/dose) alone or co-administered...
<p>The immunized mice were intranasally challenged with the reassortant RG2 (clade 2.1) or NIBRG23 (...
<p>At week 30 post immunization, H5N1 VLP immunized and control (PBS or 5 µg inactivated PR/8/34 H1N...
<p>Mice (n = 6/groups) were immunized subcutaneously on day 0 and 28. All groups were challenged int...
<p>(A–B) At six months after prime-boost immunizations with M2 VLPs, mice (n = 5) were challenged wi...
<p><b>Mice (n = 6/groups) were immunized intranasally on day 0 and 28.</b> All groups were challenge...
<p>At week 5, mice vaccinated with clade 2-dervied vaccines were challenged intranasally with a leth...
<p>Mice (n = 10/groups) were immunized subcutaneously on day 0 and 28. All groups were challenged in...
<p>Survival rates of immunized mice were monitored for 10 days after i.n. infection with mouse adapt...
<p>At 18 days following the last immunization, all mice in study group B were intranasally challenge...
<p>At week 5, mock vaccinated mice or mice vaccinated with vaccines (3 µg) were challenged intranasa...
<p>(A–B) Groups of vaccinated mice and a mock control were intranasally challenged with a lethal dos...
<p>A. Body weight loss in vaccinated/challenged C57/B6 mice. Mice were vaccinated with Pol1, Pol2, A...
<p>Mice were intramuscularly immunized with 0.1 µg of VLPs once or twice, and were challenged with a...
<p>Balb/c mice were immunized according to <a href="http://www.plosone.org/article/info:doi/10.1371/...
<p>BALB/c mice (n = 6) were immunized on day 0 and 21 with rNP (10 µg/dose) alone or co-administered...
<p>The immunized mice were intranasally challenged with the reassortant RG2 (clade 2.1) or NIBRG23 (...
<p>At week 30 post immunization, H5N1 VLP immunized and control (PBS or 5 µg inactivated PR/8/34 H1N...
<p>Mice (n = 6/groups) were immunized subcutaneously on day 0 and 28. All groups were challenged int...
<p>(A–B) At six months after prime-boost immunizations with M2 VLPs, mice (n = 5) were challenged wi...
<p><b>Mice (n = 6/groups) were immunized intranasally on day 0 and 28.</b> All groups were challenge...
<p>At week 5, mice vaccinated with clade 2-dervied vaccines were challenged intranasally with a leth...
<p>Mice (n = 10/groups) were immunized subcutaneously on day 0 and 28. All groups were challenged in...
<p>Survival rates of immunized mice were monitored for 10 days after i.n. infection with mouse adapt...
<p>At 18 days following the last immunization, all mice in study group B were intranasally challenge...
<p>At week 5, mock vaccinated mice or mice vaccinated with vaccines (3 µg) were challenged intranasa...
<p>(A–B) Groups of vaccinated mice and a mock control were intranasally challenged with a lethal dos...
<p>A. Body weight loss in vaccinated/challenged C57/B6 mice. Mice were vaccinated with Pol1, Pol2, A...
<p>Mice were intramuscularly immunized with 0.1 µg of VLPs once or twice, and were challenged with a...
<p>Balb/c mice were immunized according to <a href="http://www.plosone.org/article/info:doi/10.1371/...
<p>BALB/c mice (n = 6) were immunized on day 0 and 21 with rNP (10 µg/dose) alone or co-administered...
<p>The immunized mice were intranasally challenged with the reassortant RG2 (clade 2.1) or NIBRG23 (...